Abstract
Entamoeba histolytica is the causative agent of amoebiasis. Pathogenesis is associated with profound damage to human tissues. We previously showed that amoebae kill human cells through trogocytosis. Trogocytosis is likely to underlie tissue damage during infection, although the mechanism is still unknown. Trogocytosis is difficult to assay quantitatively, which makes it difficult to study. Here, we developed two new, complementary assays to measure trogocytosis by quantifying human cell death. One assay uses CellTiterGlo, a luminescent readout for ATP, as a proxy for cell death. We found that the CellTiterGlo could be used to detect death of human cells after co-incubation with amoebae, and that it was sensitive to inhibition of actin or the amoeba surface Gal/GalNAc lectin, two conditions that are known to inhibit amoebic trogocytosis. The other assay uses two fluorescent nuclear stains to directly differentiate live and dead human cells by microscopy, and is also sensitive to inhibition of amoebic trogocytosis through interference with actin. Both assays are simple and inexpensive, can be used with suspension and adherent human cell types, and are amenable to high-throughput approaches. These new assays are tools to improve understanding of trogocytosis and amoebiasis pathogenesis.
Graphical Abstract
Entamoeba histolytica kills human cells by performing trogocytosis. We developed new trogocytosis assays. One assay uses fluorescent nuclear stains to differentiate live (blue) and dead (turquoise) human cells.
Entamoeba histolytica is the causative agent of amoebiasis and is responsible for approximately 50 million infections/year [1]. 80% of infants in an urban slum in Dhaka, Bangladesh are infected with E. histolytica [2]. Amoebiasis results in 15,500 deaths/year in children and 67,900 deaths/year among people of all ages [3]. During infection, the actively replicating trophozoite (amoeba) form colonizes the large intestine. Symptoms range from asymptomatic infection, diarrhea, bloody diarrhea, to fatal extraintestinal abscesses. The species name (histo-: tissue; lytic-: dissolve) refers to the capacity of the amoeba to damage human tissues. However, it is still unclear how amoebae invade and damage tissues. The contact-dependent human-cell killing activity of E. histolytica [4, 5] is likely to be a major contributor to human tissue damage.
While it has been under investigation for many years, the mechanism by which amoebae kill human cells was previously unclear [6]. We defined that amoebae kill human cells via trogocytosis (trogo-: nibble) [7]. Amoebae attached to human cells and then physically extract “bites” of human cell membrane, cytoplasm and organelles, which eventually lead to human cell death. Amoebic trogocytosis required engagement of the Gal/GalNAc lectin, actin rearrangements, PI3K and EhC2PK signaling [7]. Amoebic trogocytosis was necessary for invasion of ex vivo intestinal tissue, underlining its relevance to pathogenesis [7]. Trogocytosis might be evolutionarily-conserved [8], therefore, studying this process in E. histolytica may give insight into eukaryotic trogocytosis, in addition to a better understanding of the pathogenesis of amoebiasis.
In order to better understand trogocytosis and its contribution to disease, robust cell death assays are needed. Trogocytosis is difficult to assay directly, since direct visualization of this process using microscopy is necessary. The major challenge of microscopy-based approaches is that it is necessary to apply unbiased quantification to ensure that the results are robust and reproducible. We previously used imaging flow cytometry to measure trogocytosis quantitatively [7]. In this assay, amoebae and human cells are fluorescently labeled, allowing trogocytosis to be directly measured, and Live/Dead Violet is used to stain dead (permeable) cells [7, 9, 10]. This assay allows for automated analysis of thousands of images per sample, but is limited in practicality since imaging flow cytometers are not widely available. This assay is more easily applied to study suspension cells, since cells must be in suspension during image acquisition; thus, imaging flow cytometry is limited in flexibility. While samples can be acquired from 96-well plates, imaging flow cytometry is not a truly high-throughput approach.
Cell death assays that can be applied to high-throughput techniques, like screening for small molecule inhibitors of trogocytosis, would be a useful addition to the assays in current use. Assaying human cell killing by E. histolytica is inherently challenging since readouts must specifically measure the viability of the human cells when they are mixed together with amoebae. While amoebae can kill essentially any human cell type [11], most studies have focused on either monolayers or suspension cultures, but not both, since they are typically not amenable to the same assays. Thus, flexible assays that can be applied to both monolayers and suspension cells would be beneficial.
Assays that have been previously used can be broken down into membrane permeabilization, monolayer disruption, and apoptosis assays. Membrane permeabilization assays detect intracellular components that are released into the culture supernatant by dead cells. In these assays, amoebae are co-incubated with human cells, and the supernatant is measured. LDH assays [12, 13] generally use NAD to catalyze a reporter reaction [14]. This means that other enzymatic activities in the supernatant that use NAD as a cofactor can be problematic. By contrast, the 51Cr release assay specifically measures host cell death, since in this assay, host cells are pre-labeled with 51Cr, and after incubation with amoebae, 51Cr in the culture supernatant is measured [15, 16].
Monolayer disruption assays are commonly used [17]. In these assays, amoebae are incubated with monolayers, and after washing, the remaining cells are detected by methylene blue staining [18, 19]. Similarly, calcein AM has been pre-loaded into monolayers and, after co-incubation with amoebae and washing, calcein AM signal is used as a readout for the remaining cells [20]. Trypan blue staining has also been used to stain dead cells remaining in monolayers [21, 22]. However, since amoebic proteases cause disruption of monolayers [17] and these assays call for wash steps after co-incubation with amoebae, protease activity can confound interpretation.
Finally, apoptosis assays have been used to study cell killing by amoebae [16, 23]. In some assays, care is needed to ensure the readout is specific to apoptosis. For example, DNA laddering can occur in other modes of cell death besides canonical apoptosis [24]. Annexin V staining to detect exposed phosphatidylserine should be combined with cell permeability stains like propidium iodide, to ensure that phosphatidylserine exposure is not the result of membrane damage. Apoptosis assays capture markers of apoptosis in dying cells, which differs from other cell death assays that measure cell death after it has occurred.
Here we developed two new, complementary assays for human cell death. We showed that CellTiterGlo, a luminescent readout for cellular ATP levels, can be used as a proxy for human cell viability. We also developed a confocal microscopy-based assay with fluorescent nuclear stains that quantitatively differentiate live and dead human cells. Both assays were sensitive to conditions that are known to inhibit amoebic trogocytosis. Both assays are simple and inexpensive, can be used with suspension and adherent human cell types, and can be applied to high-throughput studies.
CellTiterGlo is a very simple, high-throughput luminescent assay for cell viability that is based on cellular ATP levels. Assays for human cell killing by amoebae typically use an amoeba to human cell ratio between 1:10 and 1:40. We reasoned that since the number of human cells exceeds the number of amoebae, human cells should contribute to the majority of the CellTiterGlo luminescence signal. We first asked whether luminescence values correlated with the number of amoebae (Fig. 1A) or human Jurkat T cells per well (Fig. 1B), and found that luminescence was correlated with cell number.
Next, amoebae and Jurkat cells were co-incubated, or incubated alone as controls. In control samples, equivalent numbers of cells were loaded per well to correspond to the number of cells present in the co-incubation. As anticipated, the luminescence values were higher for control human cells than for amoebae (Fig. 1C – 1D). The luminescence values of human cells typically decreased slightly at the start of the assay, and recovered over time. When human cells and amoebae were co-incubated, the luminescence value initially corresponded to roughly the sum of the human cell and amoeba individual values, and then decreased over time. The luminescence values of the co-incubation were significantly lower than the values for human cells incubated alone (Fig. 1D). Reduced variability was observed when samples were incubated in an anaerobic GasPak (Fig. 1C – 1D), compared to an aerobic environment (Fig. S1), consistent with the microaerophilic metabolism of E. histolytica.
We next asked whether this assay was sensitive to conditions that inhibit amoebic trogocytosis. We have previously shown that amoebae kill Jurkat cells by performing trogocytosis, and that trogocytosis is inhibited by treatment with Cytochalasin D [7]. Therefore, Cytochalasin D-treated or DMSO control-treated amoebae were co-incubated with Jurkat cells, and cell viability was measured using CellTiterGlo (Fig. 1E – F). Cytochalasin D-treated amoebae were significantly less able to kill human cells, as seen by the increased CellTiterGlo signal compared to control amoebae (Fig. 1E – F). For human cells or amoebae incubated alone, Cytochalasin D treatment did not affect viability (Fig. S2A).
Amoeba must attach to human cells in order to kill them, and this attachment is mediated by the amoebic GalNAc lectin [25]. We have previously shown that engagement of the amoeba surface Gal/GalNAc lectin is necessary for trogocytosis [7]. We next tested if CellTiterGlo was sensitive to inhibition of the Gal/GalNAc lectin. Galactose-treated amoebae were significantly less able to kill human cells, compared to control mannose-treated amoebae (Fig. 1G, S2B – C). Finally, we tested knockdown mutant amoebae deficient in a rhomboid protease, EhRom1, which has a characterized role in attachment to human cells [26, 27]. There was no significant difference in the cell killing ability between EhRom1 knockdown mutants and vector control amoebae (Fig. 1H, S2D – E). This is consistent with the lack of a trogocytosis defect in EhRom1 mutants [10]. Taken together, we concluded that the CellTiterGlo assay is sensitive to the inhibition of amoebic trogocytosis.
We next sought to extend this assay to other human cell types, since many assays for cell killing are difficult to adapt to both suspension and monolayer cells. Therefore, we adapted the CellTiterGlo assay to human Caco-2 intestinal epithelial cell monolayers. CellTiterGlo luminescence values correlated closely with the number of amoebae or Caco-2 cells per well (Fig. 2A – 2B). Due to washing steps and the addition of fresh media, the luminescence values of Caco-2 cells typically decreased slightly at the start of the assay, and recovered over time. When Caco-2 cells and amoebae were co-incubated, the luminescence value initially corresponded to roughly the sum of the human cell and amoeba individual values (Fig. 2C). The luminescence values of the co-incubation were significantly lower than the values for human cells incubated alone (Fig. 2D). These results show that CellTiterGlo can be applied to assay killing of both suspension and monolayer cells.
We next developed a microscopy-based assay to directly measure human cell killing by amoebae. Since human cell nuclei are not internalized during amoebic trogocytosis [7], we devised a strategy with two different nuclear stains to distinguish living and dead human cells. Human cell nuclei were pre-labeled with Hoechst prior to co-incubation. Amoebae were not labeled with Hoechst or other dyes. During co-incubation, SYTOX green was present in the media. SYTOX green is a nucleic acid stain that is excluded by living cells, but is taken up by dead cells because they have permeable membranes. Thus, live human cells are labeled only by Hoechst, while dead human cells are dual-labeled by both Hoechst and SYTOX green (Video S1). To test this dual-stain assay, Cytochalasin D treatment was used to inhibit amoebic trogocytosis. Amoebae were treated with Cytochalasin D or DMSO, and co-incubated with human Jurkat T cells (Fig. 3A). Cytochalasin D-treated amoebae killed less than 2% of Jurkat cells in 60 minutes (Fig. 3B). By comparison, control amoebae killed 40% of Jurkat cells in 60 minutes. This assay provides a quantitative readout for cell killing, and it is robust enough to be amenable to imaging large fields of cells at low magnification (Fig. 3C). Finally, this dual-stain assay can be applied to Caco-2 epithelial cells (Fig. 3D, S3, and Videos S2 – S3), demonstrating that it is versatile with respect to human cell types.
In this study, we developed two assays for human cell killing by E. histolytica. The CellTiterGlo assay biochemically measures cellular ATP levels, and the dual-stain microscopy assay allows for direct visualization of human cell death with fluorescent stains. These assays complement the currently available cell death assays and bring their own unique strengths and weaknesses.
Trogocytosis is difficult to assay directly. In order to detect and differentiate trogocytosis from other processes, microscopy is necessary. We used microscopy to initially characterize E. histolytica trogocytosis [7]. The challenge is that it is necessary to apply unbiased quantification to ensure that microscopy results are robust and reproducible. We previously used imaging flow cytometry to directly detect and quantify trogocytosis [7]. For microscopy approaches, imaging flow cytometry is the most high-throughput and robust way to quantify images. However, this approach is limited in practicality since imaging flow cytometers are not widely available. The new assays that we developed do not take the place of image-based detection of trogocytosis, but they complement these approaches, by providing a high-throughput option and a practical solution for researchers that do not have access to imaging flow cytometry or high-resolution microscopes for direct imaging of trogocytosis.
The CellTiterGlo assay is simple and practical. Only a plate reader is required for the readout. The assay requires few manipulations and no washing steps after co-incubation; CellTiterGlo solution is added directly to cells, and after a brief incubation, luminescence is measured on a plate reader. Since there are no washing steps after co-incubation, this assay helps to overcome the challenges related to amoebic protease activity, that have confounded interpretation of monolayer disruption assays in previous studies. In the CellTiterGlo assay, even if protease activity causes human cells to be released from monolayers, these cells will still be present in the supernatant and their viability will still be assessed. By contrast, the washing steps of the monolayer disruption assays would cause detached human cells to be removed, and thus, their viability would not be assessed.
The CellTiterGlo assay is robust and requires very few steps; thus, the procedure is amenable to high throughput screening. Indeed, CellTiterGlo has previously been used in a high throughput screen for drugs that kill E. histolytica [28]. Position effects, where some wells are less reliable, were not previously noted [28], and we also did not detect position effects in this assay. The chief limitation of this assay is that it does not directly measure human cell death. Because human cells greatly outnumber amoebae in this assay, they contribute the majority of the ATP to the readout, and thus, a decrease in luminescence can be inferred to represent human cell death. Also, similar to the limitations of apoptosis assays, ATP levels are correlated with dying cells, but do not clearly define the “point of no return” when a cell is by definition, dead [29, 30]. The depletion of ATP below a threshold, combined with redox alterations, has been proposed to mark the “point of no return” [31], however, it would be difficult to infer from an assay like CellTiterGlo that the level of ATP has definitively crossed a threshold. However, the major strengths of this assay are the simplicity and adaptability to high throughput approaches. This is an area where none of the existing cell death assays are useful. Thus, we propose that this assay is most useful for initial screening of mutants or candidate inhibitors. Finally, since monolayers can be grown directly in the plates used for this assay, it is easily adaptable to both monolayers and suspension cells.
The dual-stain microscopy-based cell death assay is also simple and practical. We used confocal microscopy for imaging, but this is not necessary, as widefield fluorescence microscopes can also be used. The major strength of this assay is that it directly measures human cell death. Dead cells are labeled, thus human cell death can be directly quantified within a mixture of human cells and amoebae. Moreover, the readout for cell death in this assay is loss of membrane integrity, which is a direct marker of cells that are dead [24]. Thus, this assay, together with the imaging flow cytometry assay that we developed [7], represent the most direct assays available for human cell killing for E. histolytica. The dual-stain assay is more practical and easier to apply, since imaging flow cytometers are not widely available.
Like imaging flow cytometry, the dual-stain assay can be applied to medium throughput approaches, as it could be performed by using cells in plates and by imaging on high content screening microscopes. We did not use plates when establishing this assay, but it could easily be adapted for use with 96- or 384-well plates. The limitation of this assay is that the readout is not inherently quantitative, and requires counting of labeled cell nuclei. We did not develop automated image analysis, but this would be possible, and would ensure that the readout is unbiased and efficient. Because both stains label the same cellular feature, the nucleus, automated image analysis should be particularly robust. Finally, like the CellTiterGlo assay, the dual-stain microscopy assay is amenable to both monolayer and suspension cell cultures.
Together, these assays expand the repertoire of available tools for studying trogocytosis by E. histolytica. They are particularly simple and practical, and thus we believe they are suitable for wide application. These assays also pave the way for high-throughput studies, and they could be adapted for use in 384-well plates. The two assays could potentially be combined such that cells are first visualized using the dual-stain assay, and are subsequently lysed and assayed with CellTiterGlo. Alternatively, the CellTiterGlo assay could be used as a primary screening tool, and the dual-stain assay could be used as a secondary screening tool. Very little is known about the specific molecular mechanism underlying trogocytosis, and thus, these assays pave the way for studies that will improve understanding of this process. Since trogocytosis by E. histolytica is likely to underlie disease pathogenesis, these tools are expected to allow for an improved understanding of the mechanism of disease, and may be applicable to the development of new therapeutics.
Supplementary Material
Highlights.
Two ways to measure killing of human cells by Entamoeba histolytica were developed.
One assay measures ATP levels, and is amenable to high-throughput approaches.
The second assay uses two fluorescent stains to directly detect dead human cells.
These assays are tools to understand trogocytosis and amoebiasis pathogenesis.
Acknowledgments
We thank the MCB Microscopy Imaging Facility at UC Davis for use of core microscopes and technical assistance. We thank the Ralston lab for stimulating discussions and support. This work was supported by NIH grant 1R01AI146914 and a Pew Scholarship awarded to K.S.R., and the UC Davis Biotechnology Training Program fellowship awarded to A.B.
Footnotes
Competing Interests
The authors declare that they have no competing interests.
Declaration of interest: none.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- [1].WHO/PAHO/UNESCO report. A consultation with experts on amoebiasis. Mexico City, Mexico: 28–29 January, 1997. Epidemiol Bull, 1997. 18(1):13. [PubMed] [Google Scholar]
- [2].Gilchrist CA, Petri SE, Schneider BN, Reichman DJ, Jiang N, Begum S, Watanabe K, Jansen CS, Elliott KP, Burgess SL, Ma JZ, Alam M, Kabir M, Haque R, and Petri WA Jr. Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica. The Journal of infectious diseases, 2016. 213(10):1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016. 388(10053):1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Ravdin JI, Croft BY, and Guerrant RL. Cytopathogenic mechanisms of Entamoeba histolytica. J Exp Med, 1980. 152(2):377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Ravdin JI and Guerrant RL. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest, 1981. 68(5):1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Ralston KS and Petri WA Jr Tissue destruction and invasion by Entamoeba histolytica. Trends Parasitol, 2011. 27(6):254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Ralston KS, Solga MD, Mackey-Lawrence NM, Somlata A Bhattacharya, and Petri WA Jr. Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion. Nature, 2014. 508(7497):526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Ralston KS. Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond. Curr Opin Microbiol, 2015. 28:26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Gilmartin A, Ralston K, and Petri WJ. Inhibition of Amebic Lysosomal Acidification Blocks Amebic Trogocytosis and Cell Killing. mBio, 2017. 8(4) [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Miller HW, Suleiman RL, and Ralston KS. Trogocytosis by Entamoeba histolytica Mediates Acquisition and Display of Human Cell Membrane Proteins and Evasion of Lysis by Human Serum. mBio, 2019. 10(2) [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Ravdin JI and Guerrant RL. Studies on the cytopathogenicity of Entamoeba histolytica. Arch. Invest. Med. (Mex), 1980. 11:123. [PubMed] [Google Scholar]
- [12].Li E, Stenson WF, Kunz-Jenkins C, Swanson PE, Duncan R, and Stanley SLJ. Entamoeba histolytica Interactions with Polarized Human Intestinal Caco-2 Epithelial Cells. Infection and Immunity, 1994. 62(11):5112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Marie CS, Verkerke HP, Paul SN, Mackey AJ, Petri WA Jr. Leptin protects host cells from Entamoeba histolytica cytotoxicity by a STAT3-dependent mechanism. Infect Immun, 2012. 80(5):1934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Riss T and Niles A, Moravec R, Karassina N, Vidugiriene J, Cytotoxicity Assays: In Vitro Methods to Measure Dead Cells Assay Guidance Manual, ed. G.A. Sittampalam GS, Brimacombe K, Arkin M, Auld D, Austin C, Baell J, Bejcek B, Caaveiro JMM, Chung TDY, Coussens NP, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Haas JV, Hoare SRJ, Inglese J, Iversen PW, Kahl SD, Kales SC, Kirshner S, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr., Weidner JR, Wildey MJ, Xia M, Xu X. 2019, Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences. [PubMed] [Google Scholar]
- [15].Saffer LD and Petri WA. Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells. Infection and Immunity, 1991. 59(12):4681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Huston CD, Houpt ER, Mann BJ, Hahn CS, and Petri WA Jr. Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cellular Microbiology, 2001. 2(6) [DOI] [PubMed] [Google Scholar]
- [17].Tillack M, Nowak N, Lotter H, Bracha R, Mirelman D, Tannich E, and Bruchhaus I. Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica. Molecular and Biochemical Parasitology, 2006. 149(1):58. [DOI] [PubMed] [Google Scholar]
- [18].Bracha R and Mirelman D. Virulence of Entamoeba histolytica trophozoites. J. Exp. Med, 1984. 160:353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Teixeira JE, Sateriale A, Bessoff KE, and Huston CD. Control of Entamoeba histolytica Adherence Involves Metallosurface Protease 1, an M8 Family Surface Metalloprotease with Homology to Leishmanolysin. Infect Immun, 2012. 80(6):2165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Welter BH, Powell RR, Leo M, Smith CM, and Temesvari LA. A unique Rab GTPase, EhRabA, is involved in motility and polarization of Entamoeba histolytica cells. Mol Biochem Parasitol, 2005. 140(2):161. [DOI] [PubMed] [Google Scholar]
- [21].Ravdin JI, Murphy CF, Guerrant RL, and Long-Krug SA. Effect of Antagonists of Calcium and Phospholipase A on the Cytopathogenicity of Entamoeba histolytica. The Journal of Infectious Diseases, 1985. 152(3):542. [DOI] [PubMed] [Google Scholar]
- [22].Bracha R, Nuchamowitz Y, Leippe M, and Mirelman D. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Molecular Microbiology, 1999. 34(3):463. [DOI] [PubMed] [Google Scholar]
- [23].Seydel K and Stanley SJ. Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis. Infect Immun, 1998. 66(6):2980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, and Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death & Differentiation, 2008. 16(1):3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Petri WA Jr., Haque R, and Mann BJ. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol, 2002. 56:39. [DOI] [PubMed] [Google Scholar]
- [26].Baxt LA, Baker RP, Singh U, and Urban S. An Entamoeba histolytica rhomboid protease with atypical specificity cleaves a surface lectin involved in phagocytosis and immune evasion. Genes Dev, 2008. 22(12):1636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Baxt LA, Rastew E, Bracha R, Mirelman D, and Singh U. Downregulation of an Entamoeba histolytica rhomboid protease reveals roles in regulating parasite adhesion and phagocytosis. Eukaryot Cell, 2010. 9(8):1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Debnath A, Parsonage D, Andrade RM, He C, Cobo ER, Hirata K, Chen S, García-Rivera G, Orozco E, Martínez MB, Gunatilleke SS, Barrios AM, Arkin MR, Poole LB, McKerrow JH, and Reed SL. A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target. Nature Med, 2012. 18(6):956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Leist M, Single B, Castoldi AF, Kuhnle S, and Nicotera P. Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and Necrosis. Journal of Experimental Medicine, 1997. 185(8) [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, and Pinton P. ATP synthesis and storage. Purinergic Signal, 2012. 8(3):343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, KM Debatin, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T, Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, Lopez-Otin C, Lugli E, Madeo F, Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P, Melino S, Mizushima N, Moll U, Munoz-Pinedo C, Nunez G, Oberst A, Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T, Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG, Yuan J, Zakeri Z, Zhivotovsky B, Melino G and Kroemer G. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ, 2015. 22(1):58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Morf L RJ Pearson AS Wang, and Singh U. Robust gene silencing mediated by antisense small RNAs in the pathogenic protist Entamoeba histolytica. Nucleic Acids Research, 2013. 41(20):9424. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.